GP and MP-to-be condemns QOF and new GMS contract
By Jonn Elledge, 07 September 2009
The Devon GP and potential next Conservative MP for Totnes has condemned both QOF and the new GMS contract as 'wasted opportunities' in an exclusive GP interview.
Dr Sarah Wollaston
Chagford's Dr Sarah Wollaston, who was selected earlier this summer in Britain's first open primary, said of QOF: ‘If it can't be counted then it doesn't count. That is not great care.'
Dr Wollaston said that the introduction of the new GMS contract in 2004 had created a tick-box culture'.
She was inspired to join politics by the successful campaign to save the district hospital at nearby Moretonhampstead.
Dr Wollaston warned GPs that they should be ‘realistic' about funding.
‘I do think that at the moment GP income isn't bad,' she said. ‘We need to get away from the clocking-off mentality creeping into the profession.'
- Do you think that there is a clocking-off mentality creeping into the profession?
- Read the full interview in this week's GP dated 11 September.
Additional Information

Latest jobs Jobs web feed
- 2X Part Time Salaried GPs Deerness Park Medical Centre Competitive, Sunderland Tyne & Wear
- Full time GP partner - Isle of Man Laxey and Village Walk Health Centres Competitive, Isle of Man
- General Practitioner x 2 for MOD, RAF Leuchars, Fife MMP Competitive hourly rates offered, East Coast of Scotland
- A&E Specialty Doctors Hays Healthcare £36000.00 - £68000.00 per annum, London
- GP Locum in Dorset - Short Term Locum Fresh Medical Recruitment £70 per hour, Dorset
- GP Locum in North London - Weekday Shifts Fresh Medical Recruitment £70 per hour, London
Most read
- NHS reforms: Interactive Health Bill timeline
- Clinical Quiz on GPonline.com
- CMOs issue vitamin D warning to GPs
- RCGP demands withdrawal of Health Bill in letter to PM
- England's CMO issues cold snap warning to vulnerable patients
- BMA leaders call for Lansley to quit as Lords prepare to debate reforms
Most commented
MIMS Drug Search
Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.









